Pet companies widen production footprints from China to Australia
Bottom line
CURRENT BRIEF VERSION: Pet industry manufacturers are widening their production footprints across Asia-Pacific and beyond, with moves aimed at localizing supply, shortening delivery times, and adding capacity in premium categories. GlobalPETS reported that companies are expanding in markets including China and Australia, part of a broader push to meet rising demand while reducing supply-chain friction. Recent examples include BEWITAL opening a wet pet food plant in Weihai, China, its first production site outside Germany, Mars Royal Canin signing a cooperation memorandum to upgrade dry and wet production lines in Tianjin, and Mars opening a A$112.6 million wet cat food facility in Wodonga, Australia. That Wodonga site is expected to produce 290 million pouches annually, and Mars says it will allow 90% of its pet care products sold in Australia and New Zealand to be made locally. Similar capacity building is also underway in Europe, where GlobalPETS recently highlighted Nestlé Purina’s major Bük, Hungary, expansion, Algiecel’s new microalgae facility in Denmark, Alinatur Petfood’s added lines and warehouse in Spain, and Leiber’s facility acquisition in Romania. (globalpetindustry.com)
Why it matters: For veterinary professionals, more regional manufacturing can mean steadier supply of everyday diets, premium nutrition products, and potentially therapeutic formulations, especially as clinics and pet parents continue to expect reliable access and faster fulfillment. It also reflects where the market is heading: closer-to-market production, more automation, and more emphasis on quality control and resilience. That matters in a category where ingredient volatility, disease-related disruptions, and concentrated upstream supply can quickly affect availability, particularly for specialized diets. The European examples also show that this is not just about finished food output, but about warehousing, ingredient innovation, and export capacity. (mars.com)
What to watch: Watch for whether these footprint expansions translate into better availability of premium and veterinary-adjacent nutrition products, and whether more companies follow with local manufacturing, ingredient production, or line upgrades in key growth markets. Europe’s recent investments in automated warehousing and alternative lipid ingredients are also worth watching as signals of how companies are trying to build resilience beyond simply adding tonnage. (betagro.com)
CURRENT FULL VERSION: Pet companies are continuing to move production closer to demand centers, and the latest wave stretches from China to Australia. GlobalPETS highlighted a string of footprint expansions across strategic markets as manufacturers try to improve supply-chain efficiency, add capacity, and serve fast-growing premium pet nutrition segments more directly. The pattern is clear: build local, automate where possible, and reduce dependence on long, fragile logistics chains. (globalpetindustry.com)
This isn’t happening in isolation. Earlier GlobalPETS reporting showed similar capacity growth across Europe, including new or expanded operations in Hungary, Denmark, Spain, and Romania, reinforcing that this is part of a broader industry manufacturing cycle rather than a one-off regional story. In Hungary, Nestlé Purina invested HUF 193 billion (€502 million) to expand its Bük pet food factory with three new wet cat food production plants for Felix and Gourmet, plus a fully automated high-bay warehouse that can hold 50,000 pallets. The project adds more than 100,000 tonnes of annual capacity, lifting the site’s potential output to 500,000 tonnes, with more than 200 robots now operating there. In Denmark, Algiecel opened a microalgae production facility at Novonesis’ Kalundborg site to supply pet food and cosmetics customers, nearly quintupling capacity and positioning the company to offer a fish-oil alternative as supply pressure grows. Spain’s Alinatur Petfood added two production lines and a vertical warehouse in Lorca to improve efficiency and support international growth, while German yeast producer Leiber acquired a facility in Mizil, Romania. Together, those projects show that manufacturers are investing not only in finished-product output, but also in storage, automation, and ingredient innovation. (globalpetindustry.com)
At the same time, pet food makers are responding to a market shaped by premiumization, rising expectations around product quality, and pressure to keep shelves stocked despite ingredient and transportation volatility. That helps explain why current investments span both mainstream production and upstream inputs, from wet food lines to alternative lipid sources. (globalpetindustry.com)
In China, BEWITAL opened a new wet pet food plant in Weihai in August 2026, marking the German company’s first production facility outside its home market. Local reporting and company materials indicate the site is designed for the Chinese market and gives the company a local manufacturing base rather than relying solely on imports. Mars is also deepening its China footprint through Royal Canin: in late August 2026, Royal Canin signed a cooperation memorandum in Tianjin’s TEDA zone to expand and technologically upgrade dry and wet pet food lines, while also supporting new product development and broader pet health collaboration. Separately, Royal Canin’s Shanghai plant was recognized in June 2026 by the World Economic Forum’s Global Lighthouse Network with Distinction in Customer Centricity, underscoring how digital manufacturing capability is becoming part of the competitive story, not just added tonnage. (bewital.de)
Australia is seeing the same localization logic. In June 2026, Mars opened what it called Australia’s largest dedicated wet cat food pouch facility in Wodonga, Victoria, after investing A$112.6 million. The company said the site will produce 290 million pouches a year for brands including Whiskas, Dine, Optimum, and Advance, create more than 67 direct jobs, and enable 90% of Mars pet care products sold in Australia and New Zealand to be made locally. Mars also tied the expansion to advanced manufacturing, including autonomous mobile robots, automated packaging, AI-enabled planning tools, and renewable energy projects at the site. (mars.com)
Other players are making similar bets across the region. In Thailand, Betagro said in July 2026 that it was accelerating premium pet nutrition expansion, citing capacity growth, stronger distribution, and faster international expansion. The company reported THB 2.7 billion in 2025 pet business sales, up 25% year over year, and said first-quarter 2026 sales rose 22%, with export growth helping drive momentum. Betagro also said it is pushing further into premium, wellness, and therapeutic-adjacent segments, with products sold through channels including veterinary hospitals and clinics. (betagro.com)
Industry commentary around supply chains helps explain why these moves matter. PetfoodIndustry recently noted that manufacturers are trying to secure ingredient supply chains by improving visibility beyond direct suppliers, especially as geopolitical risk and concentrated sourcing remain concerns. IFEEDER has also warned that disruptions in vitamins and amino acids can ripple through animal food production, with particular consequences for specialized formulations, including veterinary therapeutic diets. The European projects add another layer to that story: Purina’s automated warehousing in Hungary points to a push for more efficient inventory handling, while Algiecel’s microalgae scale-up reflects active efforts to diversify ingredient sources as fish oil supply tightens. In that context, production expansion is not just about growth; it’s also about control, continuity, and responsiveness. (petfoodindustry.com)
Why it matters: For veterinary professionals, this is a manufacturing story with clinical downstream effects. When companies localize production and add digital quality controls, clinics may see fewer supply interruptions, shorter replenishment times, and more dependable access to premium and condition-specific nutrition. That’s especially relevant when diet is part of a care plan, because product gaps can force substitutions that complicate case management and pet parent compliance. The broader mix of investments also matters: more warehouse capacity, more automation, and more ingredient diversification could all support resilience in the products veterinarians rely on, not just headline increases in finished food output. (mars.com)
What to watch: The next questions are whether these investments materially improve product availability in local markets, whether more companies announce therapeutic or veterinary-channel manufacturing expansions, and how quickly automation and digital quality systems spread from flagship sites into broader pet food networks. Europe’s recent projects also suggest another watchpoint: whether alternative ingredients such as microalgae and larger automated warehousing footprints become more common tools for managing supply risk. China and Australia look like important test cases, but the bigger trend is global: pet nutrition manufacturing is being rebuilt around resilience, speed, and proximity to the pet parent. (mars.com)